We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Shellfish Exoskeletons May Reduce Radiation Poisoning

By HospiMedica staff writers
Posted on 03 Oct 2006
An investigator is currently is investigating a novel approach based on a readily available biomaterial that could potentially be used to reduce an individual's radiation dose.

At present, there are no effective methods to isolate and remove radionuclides from humans in the event of a detonation of a suitcase-sized nuclear bomb by a terrorist in a major city. More...
Dr. Tatiana Levitskaia, a scientist from Pacific Northwest National Laboratory (Richmond, WA, USA), reported on the technology at the U.S. national meeting of the American Chemical Society, held in September 2006 in San Francisco (CA, USA).

Chitosan is a natural and safe compound that has been found to be an effective chelator for a wide range of nuclides. Chitosan is obtained from chitin and found in the exoskeletons of many invertebrates such as crabs and prawns. It is one of the most abundant, readily available, and renewable natural biopolymers, second only to cellulose.

Some chitosan materials can be chemically engineered to improve their affinity to specific radionuclides. By binding to radionuclides, scientists hypothesize that chitosan may inhibit deposition in bones and vital organs such as the liver and kidney, and speed up removal from the body.

Dr. Levitskaia's investigation is targeted at finding a natural chelator such as chitosan that can safely and effectively rid the body of diverse radionuclides such as actinides, cobalt, strontium, and radium. Currently, Dr. Levitskaia's research involves the removal of cobalt from living tissues in laboratory rats. Results are expected in the fall of 2006.



Related Links:
Pacific Northwest National Laboratory

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.